Elisa Vigna
Orbassano, 10043, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Correction: Development and activity of canine B7-H3-CAR.CIK lymphocytes against sarcomas: preclinical evidence and perspectives for human clinical translation.
Journal: Cancer immunology, immunotherapy : CII
Published: December 23, 2025
Development and activity of canine B7-H3-CAR.CIK lymphocytes against sarcomas: preclinical evidence and perspectives for human clinical translation.
Journal: Cancer immunology, immunotherapy : CII
Published: March 13, 2025
Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosis.
Journal: Cancer immunology, immunotherapy : CII
Published: September 06, 2024
MET Oncogene Targeting for Cancer Immunotherapy.
Journal: International journal of molecular sciences
Published: April 30, 2024
Preclinical efficacy of a HER2 synNotch/CEA-CAR combinatorial immunotherapy against colorectal cancer with HER2 amplification.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: November 30, 2023
CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: August 16, 2023
Genetic Ablation of the MET Oncogene Defines a Crucial Role of the HGF/MET Axis in Cell-Autonomous Functions Driving Tumor Dissemination.
Journal: Cancers
Published: December 01, 2022
Correction: hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of 'MET-addicted' cancers.
Journal: Journal of experimental & clinical cancer research : CR
Published: May 23, 2022
Efficacy of CAR-T immunotherapy in MET overexpressing tumors not eligible for anti-MET targeted therapy.
Journal: Journal of experimental & clinical cancer research : CR
Published: May 09, 2022
Novel Lymphocyte-Independent Antitumor Activity by PD-1 Blocking Antibody against PD-1+ Chemoresistant Lung Cancer Cells.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 13, 2022
hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of 'MET-addicted' cancers.
Journal: Journal of experimental & clinical cancer research : CR
Published: November 22, 2021
Engineering, Characterization, and Biological Evaluation of an Antibody Targeting the HGF Receptor.
Journal: Frontiers in immunology
Published: September 15, 2021
Last Updated: 09/26/2026